Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigms orphan phase 2/3 clinical program progresses

Feb 14, 2019 at 4:02 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment